Increased retinal thickness in sarcoidosis patients with ocular system involvement visualized with optical coherence tomography: a cross-sectional study

被引:0
作者
Byg, Keld-Erik [1 ,2 ]
Ellingsen, Torkell [1 ,2 ]
Wied, Jimmi [3 ,4 ]
Peiris, Michella [1 ]
Lowater, Simon Joel [3 ,4 ]
Sejbaek, Tobias [5 ,6 ]
Grauslund, Jakob [3 ,4 ]
机构
[1] Odense Univ Hosp, Dept Rheumatol, Odense, Denmark
[2] Univ Southern Denmark, Dept Clin Res, Rheumatol Res Unit, Odense, Denmark
[3] Odense Univ Hosp, Dept Ophthalmol, Odense, Denmark
[4] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[5] Univ Hosp Southern Denmark, Esbjerg Hosp, Dept Neurol, Esbjerg, Denmark
[6] Univ Southern Denmark, Dept Reg Hlth Res, Odense, Denmark
关键词
Sarcoidosis; Neurosarcoidosis; Ocular; Retina; Optical coherence tomography; UVEITIS;
D O I
10.1007/s00296-025-05818-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study investigates the thickness of retinal structures in patients with neurosarcoidosis (NS) and ocular sarcoidosis (OS). We compared the central macular thickness (CMT), retinal thickness (RT), central nerve fiber layer (RNFL) thickness, and ganglion cell layer (GCL) thickness using optical coherence tomography. In a cross-sectional study, we categorized 97 sarcoidosis patients (185 eyes) into four groups: patients without ocular or central nervous system sarcoidosis (Non-Ocular/Non-CNS, n = 53), patients with OS (Ocular, n = 13), patients with NS (CNS, n = 16), and patients with combined OS and NS (Ocular/CNS, n = 15). The mean age was 51 (14) years. We found no overall difference between the groups in the CMT (p = 0.3), RT (p = 0.9), RNFL (p = 0.3), and GCL measurements (p = 0.9). Only in patients with a disease duration of more than five years, the CMT was significantly thicker in the Ocular group (278 mu m, p < 0.001), the CNS group (267 mu m, p = 0.04), and the Ocular/CNS group (268 mu m, p = 0.04), compared to the Non-Ocular/Non-CNS group (249 mu m). The RT was significantly thicker in the Ocular group (296 mu m, p = 0.008) and the Ocular/CNS group (291 mu m, p = 0.03) compared to the Non-Ocular/Non-CNS group (283 mu m). In the RNFL measurements, the Ocular group (33.7 mu m, p = 0.002) was thicker than the Non-ocular/Non-CNS group (29.1 mu m). We found an increased retinal thickness in patients with ocular sarcoidosis and long disease duration.
引用
收藏
页数:8
相关论文
共 33 条
  • [1] Clinical characteristics of patients in a case control study of sarcoidosis
    Baughman, RP
    Teirstein, AS
    Judson, MA
    Rossman, MD
    Yeager, H
    Bresnitz, EA
    DePalo, L
    Hunninghake, G
    Iannuzzi, MC
    Johns, CJ
    McLennan, G
    Moller, DR
    Newman, LS
    Rabin, DL
    Rose, C
    Rybicki, B
    Weinberger, SE
    Terrin, ML
    Knatterud, GL
    Cherniak, R
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (10) : 1885 - 1889
  • [2] Byg KE, 2003, SARCOIDOSIS VASC DIF, V20, P46
  • [3] A prospective, one-year follow-up study of patients newly diagnosed with neurosarcoidosis
    Byg, Keld-Erik
    Illes, Zsolt
    Sejbaek, Tobias
    Nguyen, Nina
    Moller, Soren
    Lambertsen, Kate L.
    Nielsen, Helle H.
    Ellingsen, Torkell
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2022, 369
  • [4] Role of Optical Coherence Tomography in the Prognosis of Vogt?Koyanagi?Harada Disease
    Chee, Soon-Phaik
    Afrin, Mafruha
    Tumulak, Mayjane J. G.
    Siak, Jay
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (01) : 118 - 123
  • [5] Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography
    Cutolo, Carlo Alberto
    Cere, Andrea
    Toma, Paola
    Cannavacciuolo, Tommaso
    Toma, Chiara
    Balito, Serena
    Gerli, Veronica
    Smith, Vanessa
    Sulli, Alberto
    Paolino, Sabrina
    Gotelli, Emanuele
    Traverso, Carlo Enrico
    Nicolo, Massimo
    Cutolo, Maurizio
    Hysa, Elvis
    [J]. RHEUMATOLOGY INTERNATIONAL, 2024, 44 (01) : 107 - 118
  • [6] Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography
    Eckstein, Christopher
    Saidha, Shiv
    Sotirchos, Elias S.
    Byraiah, Gita
    Seigo, Michaela
    Stankiewicz, Aleksandra
    Syc, Stephanie B.
    Ford, E'Tona
    Sharma, Srilakshmi
    Calabresi, Peter A.
    Pardo, Carlos A.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (07) : 1390 - 1398
  • [7] Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis
    Fritz, Daan
    van de Beek, Diederik
    Brouwer, Matthijs C.
    [J]. BMC NEUROLOGY, 2016, 16
  • [8] Sarcoidosis
    Grunewald, Johan
    Grutters, Jan C.
    Arkema, Elizabeth V.
    Saketkoo, Lesley Ann
    Moller, David R.
    Mueller-Quernheim, Joachim
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
  • [9] Quantitative Evaluation of Macular Vessel Density Measurement by Optical Coherence Tomography Angiography in Patients with Inactive Ocular Sarcoidosis
    Gungor, Sirel Gur
    Sezenoz, Almila Sarigul
    Adwan, Noor
    Gokgoz, Gulsah
    Aksoy, Mustafa
    Karadas, Mustafa
    Colak, Meric
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (04) : 689 - 695
  • [10] Choroidal Thickness in Ocular Sarcoidosis during Quiescent Phase Using Enhanced Depth Imaging Optical Coherence Tomography
    Gungor, Sirel Gur
    Akkoyun, Imren
    Reyhan, Nihan Haberal
    Yesilirmak, Nilufer
    Yilmaz, Gursel
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2014, 22 (04) : 287 - 293